Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

Identification of Immune Checkpoint Inhibitor–Induced Diabetes

Neoadjuvant Exercise Therapy in Prostate Cancer

Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer